BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 15090872)

  • 1. Ménière's disease.
    Minor LB; Schessel DA; Carey JP
    Curr Opin Neurol; 2004 Feb; 17(1):9-16. PubMed ID: 15090872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Menière's Disease].
    Plontke SK; Gürkov R
    Laryngorhinootologie; 2015 Aug; 94(8):530-54. PubMed ID: 26243634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Menière's disease patients?
    Claes G; Van den Hauwe L; Wuyts F; Van de Heyning P
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):413-8. PubMed ID: 21626123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H; Lange G; Mann WJ
    Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meniere's disease: Medical management, rationale for vestibular preservation and suggested protocol in medical failure.
    Christopher LH; Wilkinson EP
    Am J Otolaryngol; 2021; 42(1):102817. PubMed ID: 33202330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Practice Guideline: Ménière's Disease.
    Basura GJ; Adams ME; Monfared A; Schwartz SR; Antonelli PJ; Burkard R; Bush ML; Bykowski J; Colandrea M; Derebery J; Kelly EA; Kerber KA; Koopman CF; Kuch AA; Marcolini E; McKinnon BJ; Ruckenstein MJ; Valenzuela CV; Vosooney A; Walsh SA; Nnacheta LC; Dhepyasuwan N; Buchanan EM
    Otolaryngol Head Neck Surg; 2020 Apr; 162(2_suppl):S1-S55. PubMed ID: 32267799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive pressure therapy for Ménière's disease or syndrome.
    van Sonsbeek S; Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meniere's disease: diagnosis and new treatment perspectives].
    Quaranta A; Piazza F
    Recenti Prog Med; 2000 Jan; 91(1):33-7. PubMed ID: 10705783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.
    Gürkov R; Pyykö I; Zou J; Kentala E
    J Neurol; 2016 Apr; 263 Suppl 1():S71-81. PubMed ID: 27083887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent surgical advances and continued controversies in medically refractory Meniere's disease.
    Lucas JC; Hong RS
    Curr Opin Otolaryngol Head Neck Surg; 2023 Oct; 31(5):325-331. PubMed ID: 37266594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.
    Yamazaki T; Hayashi M; Komatsuzaki A
    Acta Otolaryngol Suppl; 1991; 481():613-6. PubMed ID: 1927484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
    Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.